Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
US |
|
Meggitt PLC
LSE:MGGT
|
UK |
|
F
|
Flutter Entertainment PLC
ISEQ:FLTR
|
IE |
|
Benitec Biopharma Inc
F:BJ9
|
US |
|
R
|
REA Group Ltd
F:R9C
|
AU |
Wall St Price Targets
ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ALNY is 454.33 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALNY's stock price target?
Price Target
454.33
USD
According to Wall Street analysts, the average 1-year price target for ALNY is 454.33 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.
What is the Revenue forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 3 years is 34%.
What is the Gross Profit forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Gross Profit over the next 3 years is 31%.
What is the Operating Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
72%
The compound annual growth rate for Operating Income over the next 3 years is 72%.
What is the Pre-Tax Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
93%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 93%.
What is the Net Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
87%
The compound annual growth rate for Net Income over the next 3 years is 87%.
